Anthony S. Marucci's most recent trade in Celldex Therapeutics Inc. was a trade of 300,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 300,000 | 300,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 26.82 per share. | 11 Nov 2024 | 11,500 | 40,284 (0%) | 0% | 26.8 | 308,430 | Common Stock |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 300,000 | 300,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 250,000 | 250,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 37.66 per share. | 15 Aug 2022 | 120,000 | 27,692 (0%) | 0% | 37.7 | 4,519,572 | Common Stock |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 15 Aug 2022 | 75,000 | 102,692 (0%) | 0% | 2.8 | 208,500 | Common Stock |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 75,000 | 25,000 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 45,000 | 26,665 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 15 Aug 2022 | 45,000 | 147,692 (0%) | 0% | 9.0 | 405,743 | Common Stock |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 250,000 | 250,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 3,537 | 0 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.00 per share. | 05 Aug 2021 | 3,537 | 27,231 (0%) | 0% | 42 | 148,554 | Common Stock |
| Celldex Therapeutics Inc. | Anthony S. Marucci | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 224,000 | 224,000 | - | - | Incentive Stock Option (right to buy) |